SiBone (SIBN)
(Delayed Data from NSDQ)
$16.81 USD
+0.20 (1.20%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $17.10 +0.29 (1.73%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
SIBN 16.81 +0.20(1.20%)
Will SIBN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SIBN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for SIBN
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
Organon (OGN) Gears Up to Report Q1 Earnings: What's in Store?
SIBN: What are Zacks experts saying now?
Zacks Private Portfolio Services
What's in Store for DENTSPLY SIRONA (XRAY) in Q1 Earnings?
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Other News for SIBN
SIBN Makes Bullish Cross Above Critical Moving Average
SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
Needham medtech/diagnostic analyst holds analyst/industry conference call
Needham medtech/diagnostic analyst holds analyst/industry conference call